ALEXIS SHAFII to Matrix Metalloproteinase 2
This is a "connection" page, showing publications ALEXIS SHAFII has written about Matrix Metalloproteinase 2.
Connection Strength
0.093
-
MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer. J Surg Res. 2002 Jan; 102(1):35-8.
Score: 0.048
-
TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo. Am J Surg. 2005 Jun; 189(6):675-9.
Score: 0.015
-
Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer. Cancer Res. 2000 Jun 15; 60(12):3207-11.
Score: 0.011
-
Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro. J Surg Res. 1999 Jun 15; 84(2):162-7.
Score: 0.010
-
Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. J Surg Res. 1999 Jan; 81(1):65-8.
Score: 0.010